Dramatic response of resistant obsessive compulsive disorder to repeated transcranial magnetic stimulation on right supplementary motor area

Iranian Journal of Medical Sciences

Volumn 34, Issue 4, 2009, Pages 295-298

  Talaei, Ali ^a   Morteza Nia, Mohammad ^a   Jafar Zadeh, Morteza ^a   Saghebi, Ali ^a   Ardani, Amir Rezaei ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Motor cortex; Obsessive compulsive disorder; Transcranial magnetic stimulation; Treatment

Indexed keywords

BUSPIRONE; CLOMIPRAMINE; OLANZAPINE; SERTRALINE;

ADULT; ANXIETY DISORDER; ARTICLE; CASE REPORT; COGNITIVE THERAPY; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; IMPULSIVENESS; MAGNETIC FIELD; MENTAL HOSPITAL; MOTOR CORTEX; OBSESSION; OBSESSIVE COMPULSIVE DISORDER; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 73349084635     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. First MB, ed. Obsessive-compulsive disorder. In: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994. p. 417-23.
2. Norberg MM, Calamari JE, Cohen RJ, Riemann BC. Quality of life in obsessive-compulsive disorder: an evaluation of impairment and a preliminary analysis of the ameliorating effects of treatment. Depress Anxiety 2008; 25: 248-59.
3. Hollander E, Kwon JH, Stein DJ, et al. Obsessive-compulsive and spectrum disorders: overview and quality of life issues. J Clin Psychiatry 1996; 57: 3-6.
4. Rothenberg A. Diagnosis of obsessive-compulsive illness. Psychiatr Clin North Am 1998; 21: 791-801.
5. Greist JH. An integrated approach to treatment of obsessive compulsive disorder. J Clin Psychiatry 1992; 53: 38-41.
6. Piccinelli M, Pini S, Bellantuono C, Wilkinson G. Efficacy of drug treatment in obsessive-compulsive disorder. A metaanalytic review. Br J Psychiatry 1995; 166: 424-43.
7. Saxena S, Rauch SL: Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am 2000; 23: 563-86.
8. George MS, Stalling LE, Speer AM, et al: Prefrontal repetitive transcranial magnetic stimulation (rTMS) changes relative perfusion locally and remotely. Hum Psychopharmacol Clin Exp 1999; 14: 161-70.
9. Prasko J, Pasková B, Záleský R,et al. The effect of repetitive transcranial magnetic stimulation (rTMS) on symptoms in obsessive compulsive disorder. A randomized, double blind, sham controlled study. Neuro Endocrinol Lett 2006; 27: 327-32.
10. Anderson B, Mishory A, Nahas Z, et al. Tolerability and safety of high daily doses of repetitive transcranial magnetic stimulation in healthy young men. J ECT 2006; 22: 49-53.
11. Bae EH, Schrader LM, Machii K, et al. Safety and tolerability of repetitive transcranial magnetic stimulation in patients with epilepsy: a review of the literature. Epilepsy Behav 2007; 10: 521-8.
12. Bridgers SL. The safety of transcranial magnetic stimulation reconsidered: evidence regarding cognitive and other cerebral effects. Electroencephalogr Clin Neurophysiol Suppl 1991; 43: 170-9.
13. Shear MK, Brown C, Clark DB: Anxiety Disorder Measures, in: Rush AJ, First MB, Blacker D. Handbook of Psychiatric Measures; 2nd ed. American Psychiatric Publishing; 2008. p. 547-9
14. Alonso P, Pujol J, Cardoner N, et al. Right prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a double-blind, placebo-controlled study. Am J Psychiatry 2001; 158: 1143-5.
15. Mantovani A, Lisanby SH, Pieraccini F, et al Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS). Int J Neuropsychopharmacol 2006; 9: 95-100.